| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |